Proteases

TNIK-IN-4 is a selective inhibitor of TNIK (TRAF2 and NCK interacting kinase) with an IC50 of 0.61 μM. It demonstrates significant inhibitory activity against the colorectal cancer cell line HCT116, making it a valuable tool for studying TNIK's role in oncogenic signaling pathways. This reagent is suited for research applications focused on cancer biology and targeted therapeutic development.

Alpha 1 Antichymotrypsin, Human Plasma is a serine protease inhibitor involved in various physiological processes. Its presence in amyloid lesions is associated with Alzheimer’s disease, making it a significant marker in neurodegenerative research. This reagent is valuable for studies focused on Alzheimer's disease pathophysiology and related therapeutic investigations.

Patamostat hydrochloride is a highly effective protease inhibitor, targeting trypsin, plasmin, and thrombin with IC50 values of 39 nM, 950 nM, and 1.9 μM, respectively. It demonstrates potential in suppressing the pathogenesis and progression of acute pancreatitis, making it a valuable tool for research focused on protease-related diseases and therapeutic interventions.

Apigenin-7-glucuronide is a potent inhibitor of Matrix Metalloproteinases (MMP), demonstrating IC50 values of 12.87 µM for MMP-3, 22.39 µM for MMP-8, 17.52 µM for MMP-9, and 0.27 µM for MMP-13. This compound's ability to modulate MMP activity makes it valuable for investigations into extracellular matrix regulation, tissue remodeling, and various inflammatory conditions. Researchers may utilize Apigenin-7-glucuronide in studies aiming to explore therapeutic interventions in diseases associated with MMP dysregulation.

Luteolin 7-O-glucuronide is a potent inhibitor of Matrix Metalloproteinases (MMPs), demonstrating IC50 values of 17.63 μM for MMP-1, 7.99 μM for MMP-3, 11.42 μM for MMP-8, 12.85 μM for MMP-9, and 0.03 μM for MMP-13. This compound is valuable for research investigating the regulation of MMP activity, which plays a critical role in extracellular matrix remodeling and various pathological conditions. It is suitable for applications in studies related to cancer metastasis, tissue repair, and inflammatory disorders.

Argatroban monohydrate is a direct and selective inhibitor of thrombin. It plays a critical role in anticoagulation therapy, particularly for patients with heparin-induced thrombocytopenia. Argatroban is widely used in research to study coagulation pathways and evaluate potential therapeutic approaches for thrombotic disorders.

α-Arbutin (4-Hydroxyphenyl α-D-glucopyranoside) is a potent tyrosinase inhibitor known for its ability to reduce melanin production, making it a valuable agent in skin lightening applications. This compound is of significant interest in research surrounding hyperpigmentation disorders, various cancer types, central nervous system disorders, osteoporosis, and diabetes, offering potential therapeutic insights into these conditions. Its mechanism of action provides a basis for exploring innovative treatments and understanding skin-related pathologies.

Methyl cinnamate (Methyl 3-phenylpropenoate) is an effective tyrosinase inhibitor, primarily utilized to prevent enzymatic browning in food products. In addition to its role in food applications, it demonstrates antimicrobial properties and exhibits antiadipogenic effects, partly mediated by the CaMKK2-AMPK signaling pathway. This compound is valuable for researchers exploring therapeutic strategies in skin pigmentation disorders and metabolic regulation.

Roseoside is a potent inhibitor targeting the HCV NS5A/B replicase, demonstrating an IC50 of 20 μM. This compound effectively interferes with HCV RNA replication in vitro and exhibits antibacterial properties against both Gram-positive and Gram-negative bacteria, as well as antifungal activity against Candida albicans. Roseoside serves as a valuable research tool for investigating bacterial infections, candidiasis, and Hepatitis A and C virus mechanisms, while demonstrating no cytotoxic effects in human systems.